PROSPER: Addressing mental health problems and preventing recidivism in the criminal justice system

Phase 2

Conditions: Symptomen van angst, (posttraumatische) stress en depressie
anxiety
Common mental health problems
depression
distress
10027946

Registration Number: NL-OMON56141

Lead Sponsor: Vrije Universiteit

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 85

Inclusion Criteria

To be eligible to participate in study phase 2, a subject must meet all of the
following criteria: - 18 years old or above; - Imprisoned in a Dutch prison; -
Convicted by the court (e.g. not held on remand); - Dutch-speaking; - Elevated
levels of psychological distress (K10 higher than15); - Imprisoned with an
estimated remaining sentence length of at least 15 weeks. An individual will be
eligible to participate in study phase 3 if: - They were a RCT participant; or
- Professionals knowledgeable about (the mental health of) prisoners; or -
Helpers, supervisors or trainers of the PM+ intervention; or - Family members
or friends of RCT participants.

Exclusion Criteria

Study phase 2
- Enclosed in a penitentiary psychiatric centre;
- Presents a potential security risk to the research team (PM+ helper and/or
research team)
- Acute medical condition;
- Imminent suicide risk or expressed acute needs/protection risks (e.g.,
someone who expresses that they are at acute risk of being assaulted or killed);
- Severe mental disorder (psychotic disorders, substance dependence) ;
- Severe cognitive impairment (e.g., severe intellectual disability or
dementia);
- Currently enrolled in a specialised psychological treatment program (e.g.,
EMDR, CBT);
- Less than two months on a stable dose of psychotropic medication (if
applicable).

Study phase 3:
- Presents a potential security risk to the research team
- Acute medical condition;
- Imminent suicide risk or expressed acute needs/protection risks.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter will be the feasibility and acceptability of PM+<br /><br>intervention. Factors relevant to that include:<br /><br>1. PM+ fidelity<br /><br>2. Perceptions about PM+ from RCT participants, professionals and helpers<br /><br>3. Indicators of intervention delivery: implementation process, adaptation, and<br /><br>dose<br /><br>4. Retention rate PM+ sessions<br /><br>5. Recruitment and consent rates</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>To assess the preliminary indications of pre to post-effects: 1) Symptoms of<br /><br>depression and anxiety (PHQ9 and GAD-7), 2) Self-identified problems<br /><br>(PSYCHLOPS), 3) Daily functioning (WHOQOL-BREF), 4) Symptoms of trauma (PCL-5),<br /><br>and 5) suicidality vulnerability (SCOPE-2)</p><br>